Form 4: Merit Medical CCO's Equity Transactions Reported

Merit Medical Systems' Chief Commercial Officer, Christian Adam Smith, reported significant equity transactions including RSU grants and tax-related share surrender.

Summary

• Christian Adam Smith, Chief Commercial Officer of Merit Medical Systems Inc. (MMSI), reported several equity transactions on February 26, 2026.
• Acquired 8,203 Restricted Stock Units (RSUs) that will vest in three equal annual installments on the first three anniversaries of the grant date.
• Acquired an additional 6,409 RSUs that will vest in two equal installments on the second and third anniversaries of the grant date.
• Acquired 6,762 shares of common stock upon the determination that conditions for performance stock units granted on March 31, 2023, had been met.
• Surrendered 2,018 shares of common stock to the Issuer for payroll and income taxes at a price of $78.02 per share.
• Beneficially owns 598 shares indirectly through a 401(k) Plan as of February 26, 2026.
• Directly owns 30,334 shares of common stock following these reported transactions.
• Holds 25,000 non-qualified stock options with an exercise price of $70.50, vesting 25% annually from October 4, 2022, and expiring October 4, 2028.
• Holds 8,259 non-qualified stock options with an exercise price of $73.95, vesting 25% annually from March 31, 2024, and expiring March 31, 2030.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider compensation transactions and does not contain information that would significantly alter the company's financial outlook or operational status.

Positives

• The grant of 8,203 and 6,409 Restricted Stock Units (RSUs) indicates ongoing equity compensation and aligns the Chief Commercial Officer's interests with shareholder value.
• The acquisition of 6,762 shares from performance stock units demonstrates the achievement of previously set performance conditions, reflecting positive operational outcomes.

Negatives

• The surrender of 2,018 shares for payroll and income taxes represents a reduction in direct beneficial ownership, although it is a common practice for equity compensation.

Future Outlook

The filing details vesting schedules for Restricted Stock Units (RSUs) and stock options, indicating future share issuances contingent on continued service and performance. The 8,203 RSUs will vest in three equal annual installments, and the 6,409 RSUs will vest in two equal installments on the second and third anniversaries of their grant date.

Industry Context

StockSavvy.ai notes that this Form 4 filing is a routine disclosure of insider transactions, reflecting standard executive compensation practices within the medical device industry. The grants of RSUs and performance-based shares are common mechanisms to incentivize and retain key management personnel, aligning their long-term interests with the company's performance.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align management incentives with shareholder interests, potentially fostering long-term value creation. The tax-related share surrender is a routine event and has minimal direct impact.
• Employees: The compensation structure for the Chief Commercial Officer may serve as a benchmark or incentive model for other key employees.

Next Steps

• The 8,203 RSUs will vest in three equal annual installments on each of the first three anniversaries of the grant date.
• The 6,409 RSUs will vest in two equal installments on each of the second and third anniversaries of the grant date.
• Non-qualified stock options will continue to become exercisable in annual installments according to their respective vesting schedules.

Key Dates

Keywords

MMSI, Merit Medical Systems, Christian Adam Smith, Chief Commercial Officer, Restricted Stock Units, RSU, Stock Options, Executive Compensation, Insider Transaction, Form 4, Equity Grant